Clinical trial Recruiting at 1 site Observational Ages 18 to 35 Women only

Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome

Official title: Association Between Serum Asprosin Concentration and Expression of Selected miRNAs With Risk Factors and Components of Metabolic Syndrome in Young Women: Diagnostic Perspectives

Run by University of Applied Sciences in Nowy Targ · NCT07917364 · Data updated 2026-11-12

This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.

More Metabolic Syndrome trials

Quick facts

Study typeObservational
Ages18 Years to 35 Years
SexWomen only
Enrollment110 (estimated)
SponsorUniversity of Applied Sciences in Nowy Targ
Academic / other
Locations1 site (Nowy Targ, Lesser Poland Voivodeship)
StatusRecruiting
StartedNovember 2026
Main results expectedMarch 2027
Study endsMarch 2027
Registry record updatedNovember 4, 2026
Trial IDNCT07917364 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Young women aged 18–35 who meet or do not meet NCEP ATP III criteria for metabolic syndrome, respectively, with no competitive sports participation or smoking.

Probably not a fit

Individuals outside the age range or with irregular cycles, pregnancy, current smoking, alcohol abuse, hormonal contraception use, or certain medications may not experience any direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational, cross-sectional case-control study enrolling young women aged 18 to 35. Researchers will measure serum asprosin concentration, six circulating microRNAs, and various metabolic and lifestyle factors from a single study visit. The goal is to see if the biomarker panel can distinguish those with metabolic syndrome from healthy controls and to explore relationships with components such as obesity, insulin resistance, and dyslipidemia. Secondary goals include comparing body composition, insulin resistance indices, lipid profiles, physical activity, diet, sleep quality, stress, and quality of life between groups. The study uses biomarker assays and questionnaire-based assessments to analyze potential diagnostic value and associations with metabolic risk factors.

Why it matters

Potential benefit: If successful, the biomarker panel could help identify metabolic risk earlier in young women and guide personalized prevention strategies.

How similar studies have gone: Previous research has shown promise for circulating microRNAs and adipokines as biomarkers in metabolic conditions, but results are heterogeneous and further validation is needed in young women.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female sex
* Age 18 to 35 years
* Regular menstrual cycle
* Not engaged in competitive sports training in any discipline
* Non-smoker
* No alcohol abuse
* No continuous pharmacotherapy, with the exception of treatment for diabetes and/or antihypertensive treatment; no use of hormonal contraception
* Written informed consent for study participation and processing of personal data

Exclusion Criteria:

* Age outside the range of 18 to 35 years
* Irregular menstrual cycle
* Pregnancy or breastfeeding
* Continuous pharmacotherapy for indications other than diabetes and/or hypertension, including any form of hormonal contraception (oral, transdermal, vaginal, implant, injectable or intrauterine)
* Competitive sports training in any discipline
* Current smoking
* Alcohol abuse
* Lack of written informed consent for study participation and processing of personal data

Where it's running

  • Institute of Medicine, University of Applied Sciences in Nowy Targ, Kokoszków 71, 34-400 Nowy Targ, Poland
    Nowy Targ, Lesser Poland Voivodeship, Poland
    Recruiting

Study contacts

  • Principal investigator: Małgorzata Kantorowicz, Ph. D. — University of Applied Sciences in Nowy Targ
  • Study coordinator: Małgorzata Kantorowicz, Ph.D.
  • Email: sknmedicus@ans-nt.edu.pl
  • Phone: +48 662 251 012

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.